1Sugita Y, Masuho Y. CD59: its role in complement regulation and potential for therapeutic use. Immunotechology 1995; 1 ( 3 ～4): 157
2Atkiuson JP, Krych M, Nickells M, et al. Complement receptors and regulatory proteins: immune adherence revisited and abuse by microorganisms. Clin Exp Immunol 1994; 97 Suppl 2:1
3Schnorr JJ, Dunster LM, Nanan R, et al. Measles virus induced down regulation of CD46 is associated with enhanced sensitivity to comlement mediated lysis of inffected cells. Eur J Immunol 1995 ;25(4) :976
4Charreau B, Cassard A, Tesson L, et al. Permanent expression of human CD59 and/or decay accelerating factor by rat endothelial cells confers protection from human complement mediated lysis. Transpl Proc 1995;27(1):336
5Nonaka M, Miwa T, Okada N, et al. Multiple isoforms of guinea pig decay accelerating factor (DAF) generated by alternative splicing. J Immunol 1995;155(6):3037
6Imrie HJ,Mcgonigle TP, Liu DT, et al. Reduction in erythrocyte comlement receptor 1 (CR1, CD35 ) and decay accelerating factor (DAF, CD56 )during normal pregnancy. J Reprod Immunol 1996;31(3) :221
7Nakamura M, Okada H, Yoshida K, et al. Quantification of the CD55 and CD59, membrane inhibitors of complement on HIV - 1 particles as a function of complement mediatde virolysis. Microbio Immunol 1996;40(8) :561
8Bjorge L,Hakulinen J,Wahlstrom T,et al. Complement regulatory proteins in ovarian malignancies. Inter J Cancer 1997; 70(1):14
9Galebskans LV.Membranc proteins as regulators of the complement system. Ukr Biokhim Zh 1996;68(3) :26
10Shenoy Scatia AM, Kwong J, Fujita T, et al. Singnal transduction through decay accelerating factor. Interaction of glycosyl phosphatidy linositol anchor and protein tyrosine kinases p561ck and p59fyn 1.J Immunol 1992;149(11):3535
